Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
2676
Crescent Biopharma
CBIO
$617M
| $779K | ﹤0.01% |
2,570
-2,693
| -51% | -$397K |
|
2677
Hycroft Mining Holding Corp
HYMC
$2.42B
| $777K | ﹤0.01% |
146,090
-77,490
| -35% | -$495K |
|
2678
MediWound
MDWD
$184M
| $776K | ﹤0.01% |
57,544
-3,462
| -6% | -$35K |
|
|
OPTU
2679
Optimum Communications Inc
OPTU
$327M
| $775K | ﹤0.01% |
168,400
-30,100
| -15% | -$148K |
|
2680
Invesco CurrencyShares Japanese Yen Trust
FXY
$450M
| $775K | ﹤0.01% |
10,900
+5,970
| +121% | +$395K |
|
2681
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.2B
| $774K | ﹤0.01% |
22,500
+1,000
| +5% | +$35.8K |
|
|
GES
2682
DELISTED
Guess Inc
GES
| $772K | ﹤0.01% |
+37,300
| New | +$686K |
|
2683
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $771K | ﹤0.01% |
5,700
-8,400
| -60% | -$1.13M |
|
2684
Essential Properties Realty Trust
EPRT
$6.62B
| $770K | ﹤0.01% |
32,800
-159,200
| -83% | -$3.47M |
|
2685
Schwab International Small-Cap Equity ETF
SCHC
$5.64B
| $768K | ﹤0.01% |
24,400
+200
| +0.8% | +$6.09K |
|
|
NM
2686
DELISTED
Navios Maritime Holdings Inc.
NM
| $766K | ﹤0.01% |
437,870
-128,944
| -23% | -$247K |
|
2687
ImmuCell
ICCC
$99.2M
| $765K | ﹤0.01% |
125,489
-12,097
| -9% | -$87.3K |
|
2688
GEE Group
JOB
$23.1M
| $762K | ﹤0.01% |
1,554,900
+442,300
| +40% | +$297K |
|
2689
Virco
VIRC
$94.2M
| $762K | ﹤0.01% |
168,630
+5,902
| +4% | +$24.9K |
|
2690
Relmada Therapeutics
RLMD
$539M
| $760K | ﹤0.01% |
+217,810
| New | +$1.91M |
|
|
AIOT
2691
PowerFleet Inc
AIOT
$588M
| $758K | ﹤0.01% |
281,910
-16,239
| -5% | -$44.5K |
|
2692
iShares MSCI Sweden ETF
EWD
$595M
| $757K | ﹤0.01% |
+23,400
| New | +$731K |
|
2693
iShares MSCI Italy ETF
EWI
$1.07B
| $757K | ﹤0.01% |
+28,100
| New | +$716K |
|
2694
Meridian
MRBK
$235M
| $757K | ﹤0.01% |
49,956
+7,166
| +17% | +$114K |
|
2695
The ONE Group
STKS
$55.6M
| $756K | ﹤0.01% |
120,000
-66,961
| -36% | -$439K |
|
|
OPRA
2696
Opera Ltd
OPRA
$1.8B
| $755K | ﹤0.01% |
120,000
+36,400
| +44% | +$183K |
|
2697
Schwab US Mid-Cap ETF
SCHM
$15.1B
| $755K | ﹤0.01% |
34,500
-14,700
| -30% | -$322K |
|
2698
iShares MSCI South Africa ETF
EZA
$593M
| $752K | ﹤0.01% |
+17,728
| New | +$726K |
|
2699
Lexicon Pharmaceuticals
LXRX
$1.03B
| $751K | ﹤0.01% |
393,285
-88,090
| -18% | -$187K |
|
2700
NI Holdings
NODK
$312M
| $750K | ﹤0.01% |
56,491
-7,000
| -11% | -$95.3K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.